Exhibit 99.3

 

First Choice Healthcare
Solutions, Inc.

 

Condensed Consolidated Pro
Forma Unaudited Financial
Statements

 

Year ended

December 31, 2014 & Three
Months Ended March 31, 2015

 

 
 

  

Table of Contents

 

  Page
   
FINANCIAL STATEMENTS  
   
Unaudited Condensed Consolidated Pro Forma Balance Sheets 2
   
Condensed Consolidated Pro Forma Unaudited Statement of Operations Three Months Ended March 31, 2015 4
   
Condensed Consolidated Pro Forma Unaudited Statement of Operations Year Ended December 31, 2014 5
   
Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements 6-8

 

 
 

  

FIRST CHOICE HEALTHCARE SOLUTIONS, INC

CONDENSED CONSOLIDATED PRO FORMA UNAUDITED BALANCE SHEET MARCH 31, 2015

  

   Balance Sheet   Balance Sheet         
   First Choice   Brevard   Pro Forma Adjustments to Reflect     
   Healthcare   Orthopaedic   The Variable Interest Entity of   Balance Sheet 
   Solutions,   Spine & Pain   Brevard Orthopaedic Spine &   Consolidated 
   Inc.   Clinic, Inc.   Pain Clinic, Inc.   Pro Forma 
   March 31,   March 31,   As Of January 1, 2014   March 31, 
   2015   2015   Dr   Cr   2015 
                     
ASSETS                  
                          
Current assets                         
Cash  $112,794   $665,679             $778,473 
Cash-restricted   384,737    -              384,737 
Accounts receivable   2,252,053    1,707,375              3,959,428 
Prepaid and other current assets   127,221    430,162              557,383 
Capitalized financing costs, current portion   68,370    4,281              72,651 
Total current assets   2,945,175    2,807,497              5,752,672 
                          
Property, plant and equipment, net of accumulated depreciation of $2,602,845 and $1,161,876   8,171,848    14,482              8,186,330 
                          
Other assets                         
Capitalized financing costs, long term portion   17,089    -              17,089 
Investment in Affiliate   -    23,960              23,960 
Patient list, net of accumulated amortization of                         
$60,000 and $55,000   240,000    -              240,000 
Patents, net of amortization of $23,875 and $19,100   262,625    -              262,625 
Deposits   2,571    -              2,571 
Total other assets   522,285    23,960              546,244 
                          
Total assets  $11,639,308   $2,845,939             $14,485,247 
                          
LIABILITIES AND STOCKHOLDERS' DEFICIT                         
Current liabilities                         
Accounts payable and accrued expenses  $1,360,890   $820,722             $2,181,612 
Stock based payable   220,000    -              220,000 
Advances   298,000    -              298,000 
Deferred rent, current portion   -    178,125              178,125 
Line of credit, short term   1,377,000    532,326              1,909,326 
Convertible note payable, short term portion   2,192,099    -              2,192,099 
Notes payable, current portion   684,904    134,172              819,076 
Unearned revenue   51,639    -              51,639 
Total current liabilities   6,184,532    1,665,345              7,849,877 
                          
Long term debt:                         
Deposits held   72,901    -              72,901 
Deferred rent   -    1,370,916              1,370,916 
Notes payable, long term portion   8,034,369    308,813              8,343,182 
Total long term debt   8,107,270    1,679,729              9,786,999 
                          
Total liabilities   14,291,802    3,345,074              17,636,876 
                          
Stockholders' deficit                         
Preferred stock, $0.01 par value; 1,000,000 shares authorized, Nil issued and outstanding   -    -              - 
Common stock, $0.001 par value; 100,000,000 shares authorized, 18,432,055 and 17,951,055 shares issued and outstanding as of March 31, 2015 and December 31, 2014, respectively   18,432    -              18,432 
Common stock, $0.01 par value; 10,000 shares authorized, issued and outstanding        100              100 
Additional paid in capital   13,151,461    461,873              13,613,334 
Accumulated deficit   (15,822,387)   (961,108)             (16,783,495)
Total stockholders' deficit   (2,652,494)   (499,135)             (3,151,628)
                          
Total liabilities and stockholders' deficit  $11,639,308   $2,845,939             $14,485,247 

  

See the accompanying notes to these unaudited condensed consolidated pro forma financial statements

 

2
 

  

FIRST CHOICE HEALTHCARE SOLUTIONS, INC

CONDENSED CONSOLIDATED PRO FORMA UNAUDITED STATEMENTS OF OPERATIONS

THREE MONTHS ENDED MARCH 31, 2015

 

   First Choice   Brevard         
   Healthcare   Orthopaedic   Pro Forma Adjustments to Reflect     
   Solutions,   Spine & Pain   The Variable Interest Entity of   Consolidated 
   Inc.   Clinic, Inc.   Brevard Orthopaedic Spine &   Pro Forma 
   3 Months Ended   3 Months Ended   Pain Clinic, Inc.   3 Months Ended 
   March 31,   March 31,   As Of January 1, 2014   March 31, 
   2015   2015   Dr   Cr   2015 
                     
Revenues:                    
Patient Service Revenue  $2,285,288   $2,626,343             $4,911,631 
Provision for bad debts   (45,224)   (9,390)             (54,614)
Net patient service revenue less provision for bad debts   2,240,064    2,616,953              4,857,017 
Rental Revenue   265,103    257,945             $523,048 
Total Revenue   2,505,167    2,874,898              5,380,064 
                          
Operating expenses:                         
Salaries & Benefits   946,120    1,752,554              2,698,674 
Other Operating expenses   451,485    -              451,485 
General & Administrative   553,284    1,428,743              1,982,027 
Depreciation and amortization   140,509    27,248              167,757 
Total operating expenses   2,091,398    3,208,545              5,299,943 
                          
Net income from operations   413,769    (333,647)             80,121 
                          
Other income (expense):                         
Miscellaneous income   750    72,977              73,727 
Amortization Financing costs   (20,686)   (988)             (21,674)
Interest expense, net   (363,144)   (7,894)             (371,038)
Total other expense   (383,080)   64,095              (318,985)
                          
Net income (loss) before provision for income taxes   30,689    (269,552)             (238,864)
                          
Income taxes (benefit)   -    -              - 
                          
NET INCOME (LOSS)  $30,689   $(269,552)            $(238,864)
                          
Net Income (loss) per common share, basic  $0.00   $(26.96)            $(0.01)
                          
Net Income (loss) per common share, diluted  $0.00   $(26.96)            $(0.01)
                          
Weighted average number of common shares outstanding, basic   18,062,466    10,000              18,072,466 
                          
Weighted average number of common shares outstanding, diluted   22,090,565    10,000              22,100,565 

  

See the accompanying notes to these unaudited consolidated condensed pro forma financial statements

 

3
 

  

FIRST CHOICE HEALTHCARE SOLUTIONS, INC

CONDENSED CONSOLIDATED PRO FORMA UNAUDITED STATEMENTS OF OPERATIONS

YEAR ENDED DECEMBER 31, 2014

 

   First Choice   Brevard         
   Healthcare   Orthopaedic   Pro Forma Adjustments to Reflect     
   Solutions,   Spine & Pain   The Variable Interest Entity of   Consolidated 
   Inc.   Clinic, Inc.   Brevard Orthopaedic Spine &   Pro Forma 
   Year Ended   Year Ended   Pain Clinic, Inc.   Year Ended 
   December 31,   December 31,   As Of January 1, 2014   December 31, 
   2014   2014   Dr   Cr   2014 
                     
Revenues:                         
Patient Service Revenue  $7,966,385   $12,667,673           $20,634,058 
Provision for bad debts   (912,782)   (37,561)             (950,343)
Net patient service revenue less provision for bad debts   7,053,603    12,630,112              19,683,714 
Rental Revenue   1,048,999    1,069,734             $2,118,733 
Total Revenue   8,102,602    13,699,846              21,802,447 
                          
Operating expenses:                         
Salaries & Benefits   4,761,573    8,053,348              12,814,921 
Other Operating expenses   1,897,780    -              1,897,780 
General & Administrative   2,434,259    6,143,605              8,577,864 
Impairment of investment   -    -              - 
Depreciation and amortization   552,084    108,873              660,957 
Total operating expenses   9,645,696    14,305,826              23,951,522 
                          
Net (loss) income from operations   (1,543,094)   (605,980)             (2,149,075)
                          
Other income (expense):                         
Miscellaneous income   3,000    -              3,000 
Other expenses   -    (63,306)             (63,306)
Amortization Financing costs   (82,744)   (3,952)             (86,696)
Interest expense, net   (866,701)   (26,904)             (893,605)
Total other expense   (946,445)   (94,162)             (1,040,607)
                          
Net loss before provision for income taxes   (2,489,539)   (700,142)             (3,189,681)
                          
Income taxes (benefit)   -    -              - 
                          
NET LOSS  $(2,489,539)  $(700,142)            $(3,189,681)
                          
Net loss per common share, basic and diluted  $(0.14)  $(70.01)            $(70.16)
                          
Weighted average number of common shares outstanding, basic and diluted   17,249,921    10,000              17,259,921 

 

See the accompanying notes to these unaudited condensed consolidated pro forma financial statements

 

4
 

 

BREVARD ORTHOPAEDIC, SPINE & PAIN CLINIC, INC.

NOTES TO PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 –DESCRIPTION OF BUSINESS

Brevard Orthopaedic, Spine & Pain Clinic, Inc. (“the Company”, “BOSPC”, “we”, “our”, or “us”) is a Florida corporation formed March 19, 1996 for the purpose of organizing and establishing a multi-specialty medical group including orthopedics (both operative and non-operative), sports medicine and pain management.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

A summary of the significant accounting policies applied in the presentation of the accompanying unaudited condensed financial statements follows:

 

General

The (a) The unaudited condensed combined pro forma balance sheet gives effect to the acquisition as if the Agreement had taken place on March 31, 2015 and combines BOSPC’s unaudited condensed balance sheet as of March 31, 2015 with FCHS’s condensed balance sheet as of March 31, 2015. (b) The unaudited condensed combined pro forma balance sheet gives effect to the acquisition as if the Agreement had taken place on March 31, 2015 and combines BOSPC’s unaudited condensed balance sheet as of March 31, 2015 with FCHS’s condensed balance sheet as of March 31, 2015 of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.

 

Use of estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the useful life of fixed assets.

 

Revenue recognition

The Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (“ASC 605-10”) which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded.

 

ASC 605-10 incorporates Accounting Standards Codification subtopic 605-25, Multiple-Element Arraignments (“ASC 605-25”). ASC 605-25 addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets. The effect of implementing 605-25 on the Company's financial position and results of operations was not significant.

 

5
 

  

BREVARD ORTHOPAEDIC, SPINE & PAIN CLINIC, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS MARCH 31, 2015

(unaudited)

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES(continued)

ASC 810 provides guidance on the accounting for variable interest entities under US GAAP. Based on management’s interpretation of the six requirements of Accounting Standards Codification subtopic 810-15-22, the Company meets the definition of the primary beneficiary with control, without a majority equity interest, for consolidation of the Company’s financial position and operations with the financial position of TBC Holdings.

 

Property and Equipment

Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 5 to 15 years.

 

Cash

The Company considers cash to consist of cash on hand and temporary investments having an original maturity of 90 days or less that are readily convertible into cash.

 

Fair value of financial instruments

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2015 and December 31, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, accounts payable line of credit and advances. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.

 

Recent accounting pronouncements

There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed financial position, results of operations or cash flows.

 

GOING CONCERN UNCERTAINTIES

  

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statement, the Company has accumulated a deficit of $961,108 as of March 31, 2015. The ability of the Company to continue as a going concern is in doubt and dependent upon achieving a profitable level of operations or on the ability of the Company to obtain necessary financing to fund ongoing operations. Management believes that its current and future plans enable it to continue as a going concern for the next twelve months.

 

To meet these objectives, the Company continues to seek other sources of financing in order to support existing operations and expand the range and scope of its business. However, there are no assurances that any such financing can be obtained on acceptable terms and timely manner, if at all. The failure to obtain the necessary working capital would have a material adverse effect on the business prospects and, depending upon the shortfall, the Company may have to curtail or cease its operations.

  

The accompanying unaudited condensed consolidated financial statements do not include any adjustment to the recorded assets or liabilities that might be necessary should the Company have to curtail operations or be unable to continue in existence.

  

NOTE 3 — LIQUIDITY

As of March 31, 2015, the Company's working capital deficit was $2,097,205. The Company’s owners have entered into an operating and control agreement giving TBC of Melbourne Holdings Inc. TBC Holdings) a, wholly owned subsidiary of First Choice Healthcare Solutions, Inc. (FCHS), a controlling variable interest in the Company. On May 5, 2015 the operating agreement was executed but made effective May 1, 2015.

 

NOTE 4 – PROPERTY AND EQUIPMENT

Property plant and equipment, at March 31, 2015, was $8,186,330 net of accumulated depreciation of $3,764,721.

 

During the three months ended March 31, 2015, $167,757 was charge to operations depreciation expense.

 

6
 

 

BREVARD ORTHOPAEDIC, SPINE & PAIN CLINIC, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS MARCH 31, 2015

(unaudited)

 

NOTE 5 – OWNERS’ EQUITY

The Company’s membership interest as of May 1, 2015 was owned by Dr. Richard Hynes (39%), Dr. Devin K. Datta (37%) and Dr. Lily Voepel (24%).

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Operating and Control Agreement for the controlling variable interest in the Company.

On May 1, 2015 the Company’s members entered into an operating and control agreement with TBC Holdings giving TBC Holdings a controlling variable interest in the Company.

 

Within ninety (90) days prior to the expiration of the initial term of this Agreement (the "Option Period"), the Manager shall have the right to exercise the option (the "Option") to extend the term of this Agreement for an additional eight (8) years and four (4) months or until December 31, 2023, on the same terms and conditions as contained in this Agreement. The Manager will provide the Practice with written notice of its intention to exercise the Option by delivering written notice thereof to the Practice within the Option Period.

 

NOTE 7 – SUBSEQUENT EVENTS

In accordance with FASB ASC 855 “Subsequent Events”, the Company has evaluated subsequent events through the date the financial statements are available to be issued, March 31, 2015.

 

Change in Members

Subsequent to the closing of the Operating and Control Agreement with TBC Holdings, Dr. Voepel terminated her relationship with the Company.

 

7